Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Am J Emerg Med ; 46: 520-524, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33191048

ABSTRACT

BACKGROUND AND AIM: New York City (NYC) is an epicenter of the COVID-19 pandemic in the United States. Proper triage of patients with possible COVID-19 via chief complaint is critical but not fully optimized. This study aimed to investigate the association between presentation by chief complaints and COVID-19 status. METHODS: We retrospectively analyzed adult emergency department (ED) patient visits from five different NYC hospital campuses from March 1, 2020 to May 13, 2020 of patients who underwent nasopharyngeal COVID-19 RT-PCR testing. The positive and negative COVID-19 cohorts were then assessed for different chief complaints obtained from structured triage data. Sub-analysis was performed for patients older than 65 and within chief complaints with high mortality. RESULTS: Of 11,992 ED patient visits who received COVID-19 testing, 6524/11992 (54.4%) were COVID-19 positive. 73.5% of fever, 67.7% of shortness of breath, and 65% of cough had COVID-19, but others included 57.5% of weakness/fall/altered mental status, 55.5% of glycemic control, and 51.4% of gastrointestinal symptoms. In patients over 65, 76.7% of diarrhea, 73.7% of fatigue, and 69.3% of weakness had COVID-19. 45.5% of dehydration, 40.5% of altered mental status, 27% of fall, and 24.6% of hyperglycemia patients experienced mortality. CONCLUSION: A novel high risk COVID-19 patient population was identified from chief complaint data, which is different from current suggested CDC guidelines, and may help triage systems to better isolate COVID-19 patients. Older patients with COVID-19 infection presented with more atypical complaints warranting special consideration. COVID-19 was associated with higher mortality in a unique group of complaints also warranting special consideration.


Subject(s)
COVID-19 Testing/methods , COVID-19/diagnosis , Emergency Service, Hospital/statistics & numerical data , Pandemics , Triage/methods , Adult , Aged , COVID-19/epidemiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , New York City/epidemiology , Retrospective Studies
2.
Emerg Med Pract ; 20(7): 1-20, 2018 07.
Article in English | MEDLINE | ID: mdl-29949707

ABSTRACT

Dyspnea is one of the most distressing symptoms experienced by dying patients, and it is a common reason for such patients to seek care in the emergency department. Many underlying disease states and acute illnesses cause shortness of breath at the end of life, and management tends to be symptomatic rather than diagnostic, particularly in those for whom comfort is the most important goal. Opioids are the most effective and widely studied agents available for palliation of dyspnea in this population, while adjuvant therapies such as oxygen, noninvasive positive pressure ventilation, and hand-held fans may also be used. Benzodiazepines may also be helpful in select patients. The early involvement of palliative medicine specialists and/or hospice services for dying patients can facilitate optimal symptom management and transitions of care.


Subject(s)
Dyspnea/therapy , Emergency Service, Hospital , Terminal Care/ethics , Terminal Care/methods , Advance Directives , Analgesics, Opioid/therapeutic use , Benzodiazepines/therapeutic use , Hospice Care , Humans , Palliative Care , Professional-Family Relations
3.
Emerg Med Pract ; 20(Suppl 7): 1-2, 2018 Jul 01.
Article in English | MEDLINE | ID: mdl-29993207

ABSTRACT

Dyspnea is one of the most distressing symptoms experienced by dying patients, and it is a common reason for such patients to seek care in the emergency department. Many underlying disease states and acute illnesses cause shortness of breath at the end of life, and management tends to be symptomatic rather than diagnostic, particularly in those for whom comfort is the most important goal. Opioids are the most effective and widely studied agents available for palliation of dyspnea in this population, while adjuvant therapies such as oxygen, noninvasive positive pressure ventilation, and hand-held fans may also be used. Benzodiazepines may also be helpful in select patients. The early involvement of palliative medicine specialists and/or hospice services for dying patients can facilitate optimal symptom management and transitions of care. [Points & Pearls is a digest of Emergency Medicine Practice.]


Subject(s)
Dyspnea/therapy , Emergency Service, Hospital , Terminal Care/ethics , Terminal Care/methods , Advance Directives , Analgesics, Opioid/therapeutic use , Benzodiazepines/therapeutic use , Hospice Care , Humans , Palliative Care
SELECTION OF CITATIONS
SEARCH DETAIL